Efficacy of topical cyclosporine A in optimizing ocular surface and relieving dry eye symptoms after cataract surgery: a systematic review and meta-analysis of randomized controlled trials

被引:0
作者
Lu, Min [1 ]
Li, Huaifeng [1 ]
Xiang, Xiang [1 ]
机构
[1] Liuyang Jili Hosp, Dept Ophthalmol, 434 Jinsha North Rd, Changsha 410300, Hunan, Peoples R China
关键词
Cyclosporine A; Dry eye disease; Cataract surgery; Ocular surface; Meta-analysis; 0.05-PERCENT; DISEASE; CONJUNCTIVA;
D O I
10.1007/s10792-025-03570-x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Dry eye symptoms and signs are common following cataract surgery. Topical cyclosporine A (CsA) is an approved treatment of moderate-to-severe dry eye disease. However, its effectiveness in managing postoperative dry eye remains debated. This systematic review and meta-analysis aimed to evaluate the efficacy of topical CsA in managing dry eye symptoms and signs after cataract surgery. Methods Randomized controlled trials (RCTs) assessing topical CsA in cataract surgery patients were identified through searches of PubMed, EMBASE, Web of Science, ClinicalTrials.gov, the Cochrane Library, and Google Scholar up to August 31, 2024. Outcomes included postoperative tear break-up time (TBUT), Schirmer's test (with or without anesthesia), the Ocular Surface Disease Index (OSDI), corneal fluorescein staining, and treatment-related adverse events. Results Nine RCTs involving 451 patients (558 eyes) were included. Topical CsA was significantly associated with prolonged TBUT (mean difference [MD] = 1.95 s, 95% confidence interval [CI]: 1.38 to 2.53, P < 0.001), improved Schirmer's test scores without anesthesia (MD = 2.14 mm, 95%CI: 0.68 to 3.59, P = 0.004), and reduced corneal fluorescein staining (standardized MD = - 1.62, 95%CI: - 3.16 to - 0.08, P = 0.039). However, CsA did not significantly improve Schirmer's test scores with anesthesia (MD = 1.73 mm, 95%CI: - 0.11 to 3.56 to 2.79, P = 0.066) or OSDI scores (MD = - 2.73, 95%CI: - 7.42 to 1.97, P = 0.255) compared to control. All treatment-related adverse events were mild. Conclusion Topical CsA significantly improves ocular surface and tear film parameters following cataract surgery and may be considered for the postoperative management of ocular surface disturbance and dry eye. However, considering the very low to moderate certainty of evidence, further high-quality RCTs are needed to validate for these findings.
引用
收藏
页数:15
相关论文
共 42 条
[1]   Evaluation of cyclosporine 0.05% and artificial tears for the management of dry eye disease following cataract surgery: a randomized controlled trial [J].
Ahmadi, Hanieh ;
Tahmasbian, Saeed ;
Janbazi, Maryam ;
Amiri, Arvin ;
Heidari, Zahra .
ANNALS OF MEDICINE AND SURGERY, 2024, 86 (04) :1983-1988
[2]   Efficacy of a new water-free topical cyclosporine 0.1% solution for optimizing the ocular surface in patients with dry eye and cataract [J].
Akpek, Esen K. ;
Sheppard, John D. ;
Hamm, Adam ;
Angstmann-Mehr, Simone ;
Kroesser, Sonja .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2024, 50 (06) :644-650
[3]   Safety and Efficacy of 0.1% Cyclosporine Solutions in Dry Eye Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials [J].
Aleksander-Ivanov, Yuri ;
Amaral, Dillan Cunha ;
Cheidde, Lidia ;
Lima, Gabriel Nery ;
Valentim, Carolina Carvalho Soares ;
Chater, Michel Sebba ;
Mora-Paez, Denisse J. ;
Guedes, Jaime .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2025, 41 (04) :199-209
[4]   Causes of vision loss worldwide, 1990-2010: a systematic analysis [J].
Bourne, Rupert R. A. ;
Stevens, Gretchen A. ;
White, Richard A. ;
Smith, Jennifer L. ;
Flaxman, Seth R. ;
Price, Holly ;
Jonas, Jost B. ;
Keeffe, Jill ;
Leasher, Janet ;
Naidoo, Kovin ;
Pesudovs, Konrad ;
Resnikoff, Serge ;
Taylor, Hugh R. .
LANCET GLOBAL HEALTH, 2013, 1 (06) :E339-E349
[5]   Preoperative optimization of ocular surface disease before cataract surgery [J].
Chuang, Jasmine ;
Shih, Kendrick Co ;
Chan, Tommy C. ;
Wan, Kelvin H. ;
Jhanji, Vishal ;
Tong, Louis .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2017, 43 (12) :1596-1607
[6]  
Chung Yeon Woong, 2013, Korean J Ophthalmol, V27, P167, DOI 10.3341/kjo.2013.27.3.167
[7]   TFOS DEWS II Definition and Classification Report [J].
Craig, Jennifer P. ;
Nichols, Kelly K. ;
Akpek, Esen K. ;
Caffery, Barbara ;
Dua, Harminder S. ;
Joo, Choun-Ki ;
Liu, Zuguo ;
Nelson, J. Daniel ;
Nichols, Jason J. ;
Tsubota, Kazuo ;
Stapleton, Fiona .
OCULAR SURFACE, 2017, 15 (03) :276-283
[8]   Topical cyclosporine A therapy for dry eye syndrome [J].
de Paiva, Cintia S. ;
Pflugfelder, Stephen C. ;
Ng, Sueko M. ;
Akpek, Esen K. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (09)
[9]   Prophylactic Therapy for Long-Term Ocular Discomfort After Cataract Surgery [J].
Di Zazzo, Antonio ;
Spelta, Sara ;
Micera, Alessandra ;
De Gregorio, Chiara ;
Affatato, Marzia ;
Esposito, Graziana ;
Balzamino, Bijorn Omar ;
Sgrulletta, Roberto ;
Coassin, Marco ;
Bonini, Stefano .
CORNEA, 2025, 44 (04) :443-449
[10]   InflammAging at Ocular Surface: Clinical and Biomolecular Analyses in Healthy Volunteers [J].
Di Zazzo, Antonio ;
Micera, Alessandra ;
Coassin, Marco ;
Varacalli, Giuseppe ;
Foulsham, William ;
De Piano, Maria ;
Bonini, Stefano .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (05) :1769-1775